URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Please provide your email address to receive an email when new articles are posted on . Transperineal prostate cancer biopsies did not cause any infections in a randomized trial. U.S. and European ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Integration of prostate MRI may improve the balance of patient harms and benefits in prostate cancer screening. Prostate MRI integration in prostate cancer (PCa) screening pathways was associated with ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

ATLANTA - Each year, millions of American men get a blood test known as a PSA, or prostate-specific antigen, test as part of their yearly checkup. PSA is a protein produced by the prostate gland. If a ...

PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the April issue of The Journal of Nuclear Medicine. By ...

One of the major concerns about using prostate specific antigen (PSA) assays for prostate cancer screening is the high rate of false-positive results that trigger unnecessary prostate biopsies. Boston ...

A new blood test that looks for circulating tumor cells could significantly improve the diagnosis of prostate cancer and avoid unnecessary biopsies and treatments. A new blood test could help many ...